For patients who received a letter on improperly disclosed information by a claims processing vendor, read more.
How you can devise a cancer prevention action plan.
How to love yourself — and your selfies — without filters or fillers.
Post Surgery Pain Mangagement Drug Treatment Study
Clinical Trial Title:
A phase 3, randomized, double-blind, placebo-controlled, multicenter, evaluation of the safety of N1539 following major surgery.
Clinical Trial Protocol ID:
16021705
Clinical Trial Investigator Name:
Adam C. Young, MD
Clinical Trial Protocol Description:
The purpose of this study is to test a study drug for safety and pain management after an elective surgery.
Clinical Trial Eligibility Criteria:
In order to participate you must be having surgery which would require a 48 hour hospitalization and not be pregnant or breastfeeding.
You will be excluded from the study if any of the following criteria apply to you:
- Are HIV positive.
- Have cancer.
- Have a known bleeding disorder.
- Have a history of alcohol abuse.
This is a partial list of inclusion and exclusion criteria.
Clinical Trial Area:
Pain Management
Contact Phone:
(312) 942-2985
Contact Name:
Sherry Robison